32nd week of 2012 patent applcation highlights part 45 |
Patent application number | Title | Published |
20120203000 | POLYMORPHIC FORMS ALPHA, BETA AND GAMMA OF RIFAXIMIN - Crystalline polymorphous forms of rifaximin (INN) antibiotic named rifaximin α and rifaximin β, and a poorly crystalline form named rifaximin γ, useful in the production of medicinal preparations containing rifaximin for oral and topical use and obtained by means of a crystallization carried out by hot-dissolving the raw rifaximin in ethyl alcohol and by causing the crystallization of the product by addition of water at a determinate temperature and for a determinate period of time, followed by a drying carried out under controlled conditions until reaching a settled water content in the end product, are the object of the invention. | 2012-08-09 |
20120203001 | FLUORESCENT BRIGHTENERS, METHODS OF PREPARATION THEREOF, FLUORESCENT BRIGHTENER COMPOSITIONS, AND METHODS OF PREPARATION AND USES THEREOF - A compound of Formula (I) | 2012-08-09 |
20120203002 | Crystalline Forms of Kinase Inhibitors - Salts of N-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl}phenyl)-N′-(3-fluorophenyl)urea and crystalline forms thereof are suitable pharmaceutical ingredients for pharmaceutical compositions useful in the treatment of disease, for example, cancer. | 2012-08-09 |
20120203003 | Continuous Flow Process For The Preparation Of Sulphoxide Compounds - A continuous micromixer based process for the synthesis of sulphoxide compounds with a reaction time of less than or equal one minute is disclosed. The process shows selectivity of >95% towards the sulphoxide compounds. | 2012-08-09 |
20120203004 | PROCESS FOR THE SYNTHESIS OF ALKYL/ARALKYL (2S)-2-(TERT-BUTOXYCARBONYL)-AMINO-2-[-8-AZABICYCLO[3.2.1]OCT-3-YL]-EXO-A- CETATE AND ANALOGS THEREOF: KEY INTERMEDIATES FOR THE PREPARATION OF DPPIV INHIBITORS - An improved process for the synthesis of intermediates like Alkyl/Aralkyl (2S)-2-(tert-butoxycarbonyl)-amino-2-[-8-azabicyclo[3.2.1]oct-3-yl]-exo-acetate and analogs thereof which are useful in the synthesis of Dipeptidyl peptidase-IV (DP-PIV) inhibitors. | 2012-08-09 |
20120203005 | POLYMORPH OF 3-(SUBSTITUTEDDIHYDROISOINDOLINONE-2-YL)-2,6-DIOXOPIPERIDINE, AND PHARMACEUTICAL COMPOSITIONS THEREOF - The present invention provides polymorph of 3-(4-amino-1-oxo-1,3-dihydro-2H-isoindole-2-yl)-piperidine-2,6-dione, and also the preparing methods and pharmaceutical compositions thereof. | 2012-08-09 |
20120203006 | PROCESSES FOR PRODUCING CYCLOALKYLCARBOXAMIDO-PYRIDINE BENZOIC ACIDS - The present invention relates to a process of providing the 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid in substantially free form (Compound 1). | 2012-08-09 |
20120203007 | POLYMORPHIC FORMS OF DEFERASIROX (ICL670A) - The invention relates to crystalline forms of 4-[3,5-bis(2-hydroxyphenyl)-[1,2,4]triazol-1-yl]benzoic acid and to its amorphous form, to processes for the preparation thereof, to compositions containing the same and their uses for the manufacture of a medicament for the treatment of the human body. | 2012-08-09 |
20120203008 | DI(AMINOGUANIDIUM) 4,4',5,5'-TETRANITRO-2,2'-BIIMIDAZOLE, AND PREPARATION METHOD THEREOF - According to the present invention, unstable hydrogen of 4,4′,5,5′-tetranitro-2,2′-biimidazole, which is a promising material for insensitive high-performance molecular explosives, may be stabilized by aminoguanidium to provide di(aminoguanidium) 4,4′,5,5′-tetranitro-2,2′-biimidazole, thereby solving the hygroscopicity of 4,4′,5,5′-tetranitro-2,2′-biimidazole, and enhancing performance and insensitivity thereof. | 2012-08-09 |
20120203009 | PROCESSES RELATING TO THE ALKYLATION OF PYRAZOLES - The present invention relates to processes for the preparation of a compound of formula (I) comprising reacting a compound of formula (IV) with a compound of formula III or (IIIA) in the presence of an acid; wherein R | 2012-08-09 |
20120203010 | CARBAZOLE COMPOUND AND USE THEREOF - A carbazole compound represented by the following formula: | 2012-08-09 |
20120203011 | PROCESS FOR PRODUCING BIS(THIETANYLTHIO)DITHIASTANNOLANE - A process for producing bis(thietanylthio)dithiastannolane of the following formula: | 2012-08-09 |
20120203012 | HETEROAROMATIC-CONTAINING COMPOUND, OPTICAL MATERIAL AND OPTICAL ELEMENT - There are provided a heteroaromatic-containing compound represented by the following general formula (1), and an optical material including the heteroaromatic-containing compound. | 2012-08-09 |
20120203013 | PROCESS FOR THE OXIDATION OF MESITOL - The invention relates to a process for the oxidation of mesitol with singlet oxygen, which is released from hydrogen peroxide, this release taking place in the presence of a bismuth compound as catalyst. In the process, 2,4,6-trimethylquinol is formed in high yield and selectivity as product, which can be used in further reactions for the synthesis of vitamins and in particular of vitamin A and vitamin E. | 2012-08-09 |
20120203014 | DERIVATIVES OF N-HYDROXYBENZAMIDE FOR TREATING HIV INFECTIONS - Herein disclosed is a method for treating patients affected by HIV comprising administering N-hydroxy-benzamide-based histone deacetylase inhibitors, such as: diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxymethyl)-naphtalen-2-yl-methyl]-ammonium chloride; 4-(2-(S)-benzoylamino-3-naphtalen-2-yl-propionylamino)-N-hydroxy-benzamide; and/or benzo[1,3]dioxole-5-carboxylic acid [1(S)-(4-hydroxycarbamoyl-phenylcarbamoyl)-2-naphtalen-2-yl-ethyl]-amide. Such histone deacetylase inhibitors are administered in a dosage ranging from 50 to 200 mg/day, preferably from 100 to 200 mg/day, so as to obtain a blood concentration between 125 and 250 nM. | 2012-08-09 |
20120203015 | PROCESS AND APPARATUS FOR PREPARING ALKYLENE OXIDES AND ALKYLENE GLYCOLS - An integrated process for preparing alkylene oxides and alkylene glycols is described. For this purpose, an alkylene oxide plant and an alkylene glycol plant are combined with one another and the water originating from the alkylene oxide plant and also other constituents of the reaction mixture are introduced into the alkylene glycol plant. In this way, alkylene glycols which have been produced in the alkylene oxide plant can be recovered as materials of value and the water circulation into the alkylene glycol plant can be eliminated or drastically reduced. In addition, the energy-intensive treatment of the process water from the alkylene oxide plant can be dispensed with. The integration of the two processes leads overall to better energy efficiency and conservation of resources in the work-up of residues from the process. | 2012-08-09 |
20120203016 | High Oleic Imidazolinone Resistance Sunflower - A sunflower seed having imidazolinone resistance and an oleic acid content of greater than 85 percent is provided. Sunflower cultivars designated E83329, OI1601A, OI2653R, and OI1601B and having high oleic acid and imidazolinone resistance, plants and seeds of the E83329, OI1601A, OI2653R, and OI1601B sunflower cultivars, methods for producing a sunflower plant produced by crossing the E83329, OI1601A, OI2653R, or OI1601B cultivar with itself or with another sunflower plant, and hybrid sunflower seeds and plants produced by crossing the E83329, OI1601A, OI2653R, or OI1601B cultivar with another sunflower line or plant are also provided. | 2012-08-09 |
20120203017 | Method for Purifying Fatty Acid Alkyl Ester Greatly Loaded with Saponification Products - A method for the continuous extraction of impurities, in particular saponification products, from a fatty acid alkyl ester phase produced by transesterification of vegetable or animal oils or fats with a great tendency to form saponification products, by means of an aqueous, acid glycerol phase containing a complexing agent. | 2012-08-09 |
20120203018 | Tailored Oils Produced from Recombinant Oleaginous Microorganisms - Methods and compositions for the production of oil, fuels, oleochemicals, and other compounds in recombinant microorganisms are provided, including oil-bearing microorganisms and methods of low cost cultivation of such microorganisms. Microalgal cells containing exogenous genes encoding, for example, a lipase, a sucrose transporter, a sucrose invertase, a fructokinase, a polysaccharide-degrading enzyme, a keto acyl-ACP synthase enzyme, a fatty acyl-ACP thioesterase, a fatty acyl-CoA/aldehyde reductase, a fatty acyl-CoA reductase, a fatty aldehyde reductase, a fatty acid hydroxylase, a desaturase enzyme, a fatty aldehyde decarbonylase, and/or an acyl carrier protein are useful in manufacturing transportation fuels such as renewable diesel, biodiesel, and renewable jet fuel, as well as oleochemicals such as functional fluids, surfactants, soaps and lubricants. | 2012-08-09 |
20120203019 | Method For Producing Organo-Oligo Silsesquioxanes - Silsesquisiloxanes are produced in high yield and purity in a minimal number of process steps by reacting quaternary ammonium silicates with disiloxanes in a precipitant liquid which causes the silsesquisiloxane product to be precipitated in high purity. | 2012-08-09 |
20120203020 | MULTI-COMPONENT POLYMERIZATION INHIBITORS FOR ETHYLENICALLY UNSATURATED MONOMERS - The invention provides a composition and a method of using the composition for inhibiting the unwanted polymerization of ethylenically unsaturated monomers. The composition is prepared by reducing a nitroxide stable free radical to its corresponding hydroxylamine through reaction with a dialkyl/aryl hydroxylamine and subsequent addition of a polymerization prevention component selected from phenolic antioxidants, phenylenediamine and phenylenediamine derivatives, or phenothiazine and phenothiazine derivatives targeted towards ethylenically unsaturated monomers. The conversion of the nitroxide by the dialkyl/aryl hydroxylamine is to prevent it or the polymerization prevention component from being “spent” by reaction with each other, impurities or any other incompatible components. This allows previously incompatible combinations to now work effectively. In fact, the combination is more efficacious as the combination exerts a synergy due to the presence of various polymerization prevention reagents. The composition is a synergistic combination of various polymerization inhibition compounds for the inhibition of the unwanted polymerization of ethylenically unsaturated monomers. | 2012-08-09 |
20120203021 | METHOD FOR PRODUCING CYANOACRYLATE ESTERS IN THE PRESENCE OF TRANSITION METAL CATALYSTS - The present invention relates to a method for producing cyanoacrylic acid esters. The method is based substantially on a transesterification reaction, wherein the transesterification reaction is performed in the presence of at least one transition metal catalyst that is formed by reacting at least one hydroxyl group-containing support material with at least one transition metal alkoxide. | 2012-08-09 |
20120203022 | METHOD FOR PRODUCING URETHANES - The content of the invention is a process for preparing urethanes by reaction of aromatic amines with a dialkyl carbonate, wherein the alkyl radical of the organic dialkyl carbonate comprises 4-18 carbon atoms and is branched in the 2 position, and the reaction is performed in the presence of a substoichiometric amount of base, based on the amino groups. | 2012-08-09 |
20120203023 | Process For Preparing A Phenylalanine Derivative - A novel process for the preparation of a phenylalanine derivative of formula (I): | 2012-08-09 |
20120203024 | PHOTOACID GENERATOR, METHOD FOR PRODUCING THE SAME, AND RESIST COMPOSITION COMPRISING THE SAME - A photoacid generator represented by the following formula (1), a method for producing the photoacid generator, and a resist composition containing the photoacid generator are provided. | 2012-08-09 |
20120203025 | VINYL ESTER PRODUCTION FROM ACETYLENE AND CARBOXYLIC ACID UTILIZING HOMOGENEOUS CATALYST - A process for the selective production of vinyl ester by the reaction of a carboxylic acid with acetylene with a homogeneous catalyst is disclosed and claimed. In one aspect, esters of neoacids are provided. | 2012-08-09 |
20120203026 | METHOD FOR MANUFACTURING TRICYCLODECANE MONO-METHANOL MONOCARBOXYLIC ACID DERIVATIVE - Provided is a method for manufacturing a tricyclodecane mono-methanol monocarboxylic acid derivative that can be used as a raw material for high heat-resistant alicyclic polyesters and the like. | 2012-08-09 |
20120203027 | PROCESS FOR PREPARATION OF DIETHYLENETRIAMINEPENTAACETIC ACID DERIVATIVE, AND DIETHYLENETRIAMINEPENTAACETIC ACID DERIVATIVE - The objective of the present invention is to provide a process for simple and efficient preparation of an intermediate compound to synthesize a gadolinium complex having a substituent for improving a retention property in blood time and specificity to an intended organ. The objective of the present invention is also to provide an intermediate compound produced by the said production process. The process for preparation of the diethylenetriaminepentaacetic acid derivative (I): | 2012-08-09 |
20120203028 | PROCESS FOR THE PREPARATION OF PURE ACRYLATE ESTERS - The present invention provides a process for manufacturing acrylate esters of trinol, dinol, and didinol, which avoids the undesired thermopolymerization of the esters and provides highly pure monomers for the preparation of plastic lenses. | 2012-08-09 |
20120203029 | Production of acetates from acetic acid and alcohols - A process for producing at least one acetate from acetic acid and at least one alcohol by employing multiple cycles of reacting acetic acid to produce a reaction product including at least one acetate, unreacted acetic acid, unreacted alcohol, and water, followed by drying the reaction product to remove water therefrom. Such process provides for improved yields of acetate. | 2012-08-09 |
20120203030 | PHOTOACID GENERATOR, METHOD FOR PRODUCING THE SAME, AND RESIST COMPOSITION COMPRISING THE SAME - A photoacid generator represented by the following formula (1), a method for producing the photoacid generator, and a resist composition containing the photoacid generator are provided. | 2012-08-09 |
20120203031 | Sustainable chemical process for reduction of nitro compounds (R-NO2) or nitroso compounds (R-NO) containing sulphonic or carboxylic group into corresponding amino compounds (R-NH2) with inherent recycle of all acidic streams generated in synthesis - The process of the present invention creates a sustainable and closed water loop allowing inherent recycles of all liquid streams generated in the process. The liquid streams generated during the process of the invention are inherently recycled completely, making the process of the present invention a zero liquid discharge process which is environmentally friendly and sustainable. This invention further relates to a sustainable chemical process of reduction of R—NO | 2012-08-09 |
20120203032 | PROCESS FOR PRODUCING AND PURIFYING A CONCENTRATED LACTIC SALT - The present disclosure relates to a process for preparing a lactic salt from a lactide starting material. In particular, the present disclosure is directed to the production of potassium lactate, wherein the potassium lactate has a desirable neutral odor and a concentration greater than 75%, and wherein the potassium lactate possesses desirable properties for food applications. | 2012-08-09 |
20120203033 | PREPARATION OF PRIMARY DIAMINES HAVING A LINEAR MAIN CHAIN FOR POLYAMIDE SYNTHESES - The invention provides a method to produce primary diamines by catalytic conversion of diols having a linear main chain of from 4 to 31 carbon atoms into the corresponding diamines. The reaction is conducted in a liquid or supercritical phase and is catalyzed by a homogeneous ruthenium-containing complex. The primary diamines obtained may be suitable for polyamide syntheses. | 2012-08-09 |
20120203034 | COMPOSITE CATALYST AND USING THE SAME FOR MAKING ISOPROPYL ALCOHOL - Isopropyl alcohol is a very useful chemical that is widely used in the industry as a solvent. Economical and easy process to make ispopropyl alcohol using novel composite catalyst is described in the instant application. Production of isopropyl alcohol (IPA) from dimehtyl ketone (DMK) and hydrogen (H | 2012-08-09 |
20120203035 | HYDROCARBON SELECTIVE OXIDATION WITH HETEROGENOUS GOLD CATALYSTS - This invention concerns processes for the oxidation of hydrocarbons such as methane to form alcohols such as methanol using heterogeneous gold-containing supported catalysts. Hydrogen peroxide is used as the oxidant. The hydrogen per-oxide can be made in situ. | 2012-08-09 |
20120203036 | GAS PHASE SYNTHESIS OF 2,3,3,3-TETRAFLUORO-1-PROPENE FROM 2-CHLORO-3,3,3-TRIFLUORO-1-PROPENE - A multi-step process for preparing 2,3,3,3-tetrafluoro-1-propene comprising the steps of (a) contacting a starting material comprising 2-chloro-3,3,3-trifluoro-1-propene with hydrogen fluoride in the presence of activated first catalyst selected from the group consisting of antimony-halides, iron-halides, titanium halides, and tin-halides, to produce an intermediate composition; and (b) contacting said intermediate composition with a second catalyst of activated carbon to produce a final product comprising 2,3,3,3-tetrafluoro-1-propene. | 2012-08-09 |
20120203037 | PROCESS FOR PURIFYING (HYDRO) FLUOROALKENES - The invention relates to a process for removing one or more undesired (hydro)halocarbon compounds from a (hydro)fluoroalkene, the process comprising contacting a composition comprising the (hydro)fluoroalkene and one or more undesired (hydro)halocarbon compounds with an aluminium-containing absorbent, activated carbon, or a mixture thereof. | 2012-08-09 |
20120203038 | VERSATILE SYSTEMS FOR CONTINUOUS IN-LINE BLENDING OF BUTANE AND PETROLEUM - A system and method are provided for in-line processes of blending butane into gasoline streams, and for blending butane into a gasoline stream at any point along a petroleum pipeline. The invention additionally provides a method for measuring the vapor pressure and vapor to liquid ratio of the gasoline, both upstream and downstream of the blending operation, as well as the sulfur content of the butane entering the blending operation. The blending operation can be controlled to ensure that the blended gasoline meets EPA requirements for vapor pressure and sulfur content of gasoline. The invention further provides a method for accessing and monitoring the operation off-site. | 2012-08-09 |
20120203039 | Process to hydrodesulfurize pyrolysis gasoline - A single stage process for treating pyrolysis gasoline containing acetylene, diolefins, sulfur compounds and nitrogen compounds to react a sufficient amount of said acetylene and diolefins with hydrogen to produce saturated products and hydrogen sulfide to provide a pyrolysis gasoline product suitably for use as gasoline blending stock comprising: feeding pyrolysis gasoline and hydrogen at a mol ratio of hydrogen to pyrolysis gasoline of at least 0.5:1 and preferably in the range of 1:1 to 3:1 to a hydrodesulfurization zone containing a hydrodesulfurization catalyst such as cobalt/molybdenum under vapor phase conditions at a pressure in the range of 200 to 500 psig at a temperature in the range of 550° F. to 850° F. The operating temperature is at least above the dew point of the mixture of pyrolysis gasoline and hydrogen, preferably in a range 50 to 400° F. above said dew point. | 2012-08-09 |
20120203040 | Process for the Production of Paraffinic Hydrocarbons - Reaction catalysts and supports as disclosed herein are utilized in a process for converting carboxylic acids, which are derived from molecules found in various feedstocks of biological origin as well as various byproducts of industrial processes, to linear paraffinic hydrocarbons, the latter being capable of use in various applications, including as an alternative source of fuel. | 2012-08-09 |
20120203041 | LUBRICATING OIL ADDITIVE AND LUBRICATING OIL COMPOSITION CONTAINING SAME - An overbased salt of an oligomerized alkylhydroxyaromatic compound for use in a lubricating oil composition is disclosed, wherein the alkyl group of the alkylhydroxyaromatic compound is derived from an olefin mixture comprising propylene oligomers having an initial boiling point of at least about 195° C. and a final boiling point of greater than 325° C. and up to about 400° C. as measured by ASTM D86. Also disclosed is a propylene oligomer having an initial boiling point of at least about 195° C. and a final boiling point of greater than 325° C. and up to about 400° C. as measured by ASTM D8, wherein the propylene oligomer contains a distribution of carbon atoms that comprise at least about 50 weight percent of C | 2012-08-09 |
20120203042 | SYSTEMS AND PROCESSES FOR CATALYTIC PYROLYSIS OF BIOMASS AND HYDROCARBONACEOUS MATERIALS FOR PRODUCTION OF AROMATICS WITH OPTIONAL OLEFIN RECYCLE, AND CATALYSTS HAVING SELECTED PARTICLE SIZE FOR CATALYTIC PYROLYSIS - This invention relates to compositions and methods for fluid hydrocarbon product, and more specifically, to compositions and methods for fluid hydrocarbon product via catalytic pyrolysis. Some embodiments relate to methods for the production of specific aromatic products (e.g., benzene, toluene, naphthalene, xylene, etc.) via catalytic pyrolysis. Some such methods may involve the use of a composition comprising a mixture of a solid hydrocarbonaceous material and a heterogeneous pyrolytic catalyst component. In some embodiments, an olefin compound may be co-fed to the reactor and/or separated from a product stream and recycled to the reactor to improve yield and/or selectivity of certain products. The methods described herein may also involve the use of specialized catalysts. For example, in some cases, zeolite catalysts may be used. In some instances, the catalysts are characterized by particle sizes in certain identified ranges that can lead to improve yield and/or selectivity of certain products. | 2012-08-09 |
20120203043 | PROCESS FOR IMPROVING THE ENERGY DENSITY OF FEEDSTOCKS USING FORMATE SALTS - Methods of forming liquid hydrocarbons through thermal deoxygenation of cellulosic compounds are disclosed. Aspects cover methods including the steps of mixing a levulinic acid salt-containing feedstock with a formic acid salt, exposing the mixture to a high temperature condition to form hydrocarbon vapor, and condensing the hydrocarbon vapor to form liquid hydrocarbons, where both the formic acid salt and the levulinic acid salt-containing feedstock decompose at the high temperature condition and wherein one or more of the mixing, exposing, and condensing steps is carried out a pressure between about vacuum and about 10 bar. Other methods and parameters for generating energy dense liquid hydrocarbons are also disclosed and claimed. | 2012-08-09 |
20120203044 | PROCESS FOR UPGRADING A PYROLYSIS OIL, IN PARTICULAR IN A REFINERY - The invention relates to a process for upgrading a pyrolysis oil comprising the following steps: hydrodeoxygenation treatment ( | 2012-08-09 |
20120203045 | PROCESS FOR PRODUCING AN SI-BONDED FLUIDIZED-BED CATALYST - The invention relates to a process for producing a particulate, Si-bonded fluidized-bed catalyst having improved abrasion resistance, which comprises the steps
| 2012-08-09 |
20120203046 | HIGH STRENGTH SAPO-34 MICROSPHERE CATALYST, METHOD FOR PREPARING SAME, AND METHOD FOR PREPARING LIGHT OLEFINS USING SAME - The present invention relates to a high-strength silicoaluminophasphate-34 (SAPO-34) microsphere catalyst, a method for preparing the same, and a method for preparing light olefins by using the same, and when described in more detail, the present invention relates to a method for preparing a SAPO-34 microsphere catalyst, including: spray drying a mixed slurry including a matrix, a binder, an additive, and the like to a SAPO-34 slurry prepared by a hydrothermal synthesizing method using various organic templates such as tetraethylammonium hydroxide (TEAOH), and the like alone or in mixtures to prepare microspheres, and firing the microspheres, and to a SAPO-34 microsphere catalyst for a circulating-fluidized bed reactor, prepared by the preparation method. The SAPO-34 microsphere catalyst of the present invention has excellent reaction activity while having high strength, and thus is appropriate for use in a circulating-fluidized bed reactor requiring high strength of the catalyst. Further, the SAPO-34 microsphere catalyst has a long life-span and excellent conversion rate of C | 2012-08-09 |
20120203047 | PROCESS AND CATALYST FOR CRACKING OF ETHERS AND ALCOHOLS - A process for the production of olefins from at least one of an alcohol and ether, the process including: contacting at least one alcohol or ether with a hydrofluoric acid-treated amorphous synthetic alumina-silica catalyst under decomposition conditions to produce an olefin. Also disclosed is a process for the production of isobutylene from methyl tertiary butyl ether, the process including: feeding methyl tertiary butyl ether (MTBE) to a reactor having at least one reaction zone containing a hydrofluoric acid-treated amorphous synthetic alumina-silica catalyst; contacting the MTBE with the hydrofluoric acid-treated amorphous synthetic alumina-silica catalyst under decomposition conditions to produce a reactor effluent comprising isobutylene, unreacted MTBE, heavies, and methanol; feeding the reactor effluent to a first distillation column; separating the isobutylene from the unreacted MTBE, heavies, and the methanol in the first distillation column to recover a first bottoms fraction comprising heavies, unreacted MTBE, and methanol and an isobutylene-rich overheads fraction. | 2012-08-09 |
20120203048 | METHOD FOR MANUFACTURING CATALYST - A method for manufacturing a catalyst, which comprises regenerating a catalyst comprising a zeolite as an active ingredient and having an ethylene conversion lowered through reaction of producing propylene by bringing into contact with ethylene in a vapor phase, by bringing the catalyst into contact with a gas which does not comprise oxygen and comprises hydrogen having a hydrogen partial pressure of 0.01 MPa or more as an absolute pressure thereof. | 2012-08-09 |
20120203049 | HEAT EXCHANGE DEVICE AND A METHOD OF MANUFACTURING THE SAME - A method of manufacturing a heat exchange device having at least one heat exchange tube is disclosed. The method includes: determining a peak heat flux area of the at least one heat exchange tube; and disposing in the at least one heat exchange tube an flow enhancement device for creating a desirable flow pattern in a process fluid flowing through the at least one heat exchange tube; wherein the flow enhancement device is disposed in the at least one heat exchange tube upstream of or at the determined peak heat flux area of the at least one heat exchange tube. | 2012-08-09 |
20120203050 | METALLIC NANOPARTICLES, PREPARATION AND USES THEREOF - The present application relates to activable nanoparticles which can be used in the health sector, in particular in human health, to disturb, alter or destroy target cells, tissues or organs. It more particularly relates to nanoparticles which can generate a significantly efficient therapeutic effect, when exposed to ionizing radiations. The inventive nanoparticle is a metallic nanoparticle having, as the largest size, a size comprised between about 80 and 105 nm, the metal having preferably an atomic number (Z) of at least 25. The invention also relates to pharmaceutical compositions comprising a population of nanoparticles as defined previously, as well as to their uses. | 2012-08-09 |
20120203051 | TREATMENT OF CANCER USING THE SODIUM SALT OF A BENZOIC ACID DERIVATIVE - The present invention provides a method of treating cancer using the sodium salt of a benzoic acid derivative, alone or in combination with standard treatments such as chemotherapy and radiotherapy. | 2012-08-09 |
20120203052 | THERAPEUTIC REGIMEN FOR TREATING CANCER - The invention provides a method for treating cancer in a human comprising administering to the human a dose of a pharmaceutical composition comprising (i) a pharmaceutically acceptable carrier and (ii) an adenoviral vector comprising a nucleic acid sequence encoding TNF-α operably linked to a promoter, wherein the dose comprises about 1×10 | 2012-08-09 |
20120203053 | SEQUENTIAL OPTIMIZATIONS FOR TREATMENT PLANNING - A method and apparatus for radiation treatment planning are described. The method includes receiving a plurality of radiation treatment-planning parameters, and sequentially optimizing the plurality of radiation treatment-planning parameters. | 2012-08-09 |
20120203054 | Method and Apparatus for Determining the Proximity of a TMS Coil to a Subject's Head - A proximity sensor for a transcranial magnetic stimulation (TMS) system detects the proximity of a TMS coil assembly to a position at which the coil is to receive pulses during TMS treatment and provides feedback to the operator so that the operator may adjust the TMS coil assembly to maintain optimal positioning during treatment. A flexible substrate containing a sensor or sensor array is disposed between the TMS coil assembly and the position such that the coupling of the TMS coil assembly to the position may be detected by the sensor(s). Sensor outputs are processed by signal processing circuitry to provide an indication of whether the TMS coil assembly is properly disposed with respect to the position during TMS treatment. A display provides an indication of how to adjust the TMS coil assembly to improve the positioning of the TMS coil assembly. | 2012-08-09 |
20120203055 | APPARATUS FOR TREATING AND/OR PREVENTING DISEASES AND FUNCTIONAL DISORDERS OF EXTERNAL GENITAL ORGANS - The present invention relates to a method for treatment and/or prevention of diseases and functional disorders of external genital organs and a device for realizing the same. The method comprises exposure of an organ to periodic action of vacuum and/or mechanical oscillations and low-frequency pulsed magnetic field and is characterized in that the organ is additionally exposed to a light field and the light exposure of different wavelengths is combined. | 2012-08-09 |
20120203056 | ANATOMIC FIT OF A PERCUTANEOUS VAD FOR RIGHT HEART SUPPORT - An apparatus is disclosed including: a cannula having a shape closely matched to the anatomy of the right ventricle of the human heart, where the cannula has an outflow port configured to be located proximal the pulmonary artery and an inflow port located proximal the inferior vena cava. In some embodiments, the cannula is a close fit to the anatomy of at least 90%, 95%, or more of the population. | 2012-08-09 |
20120203057 | Moxa Burning Bowl - A moxa burning bowl is provided for application of heat treatment to body portions of a user, with the bowl having a flexible ring-shaped base member of a flexible cloth-like exterior and granular material therein, shaped in a ring-like or torus-like configuration, and having a generally concave shaped upper dish-like member and an open bottom, defining a zone therebetween when the bowl is placed on an exterior surface of a patient/user, for treatment. Moxa sticks or cones are carried by the dish-like member, projecting upwardly therefrom, and situated in sockets of the dish-like member, with the dish-like member having an upstanding periphery, enabling the dish-like member to catch fallen ash from burning moxa sticks or cones carried by the bowel. | 2012-08-09 |
20120203058 | MOTION ACTIVATED ELECTRONIC THERAPEUTIC CUE DEVICE AND METHOD - The present invention relates to a device and method for presenting audio, voice, and tone cues to aid in the rehabilitation of repetitive actions utilizing a device for actions such as eating, drinking or walking. The device also provides a diminisher function for varying the cues. | 2012-08-09 |
20120203059 | Coated Pelvic Implant Device and Method - Implant systems and methods are provided to include a treatment material with a pelvic implant device. The pelvic implant device, such as an incontinence sling, can include the treatment coating combination of a material, such as Phosphorylcholine (PC), and an infection prevention material, such as InhibiZone® (IZ) technology. The treatment material can be coated onto, or impregnation or integrated with, polypropylene mesh in order to prevent infection and promote healing. | 2012-08-09 |
20120203061 | BARIATRIC DEVICE AND METHOD FOR WEIGHT LOSS - A bariatric device for use in inducing weight loss, comprising a cardiac element and a fixation element wherein the fixation element attaches the cardiac element to the upper stomach to allow the cardiac element to apply at least intermittent pressure to the upper stomach which produces a satiety signal to the user, giving the recipient a feeling of fullness and reducing his or her hunger feelings. The device may also contain an esophageal element which is connected to the cardiac element by a connecting element. | 2012-08-09 |
20120203063 | TREATMENT TOOL FOR ENDOSCOPE - A treatment tool for endo scope includes a pair of forceps members supported by a forceps rotation axis such that they can rotate relatively, an operation part for performing an open-close operation of the pair of forceps members, an operation wire that connects the pair of forceps members and the operation part, an insertion part which the operation wire is inserted into, a cover member that secures the forceps rotation axis to the insertion part, a connection member including a link rotation axis, provided at a distal-end part of the operation wire, and a pair of link members, first end parts of each being rotatably connected via respective rotation axis members to a proximal-end part of each of the pair of forceps members, and second end parts of each being rotatably connected to the link rotation axis. The cover member includes restricting parts. | 2012-08-09 |
20120203064 | Percutaneous Renal Access System - A method for creating a tract in retrograde fashion for nephrostomy tube creation comprising the steps of providing a puncture wire having a tissue penetrating tip shielded in a sheath, inserting the puncture wire and sheath through a channel in an ureteroscope, advancing the puncture wire from the sheath while visualizing under direct vision a position of the puncture wire, advancing the puncture wire through a selected calyx, and inserting antegrade a coaxial catheter over the puncture wire. | 2012-08-09 |
20120203065 | GLOBAL AND SEMI-GLOBAL REGISTRATION FOR IMAGE-BASED BRONCHOSCOPY GUIDANCE - Two system-level bronchoscopy guidance solutions are presented. The first incorporates a global-registration algorithm to provide the physician with updated navigational and guidance information during bronchoscopy. The system can handle general navigation to a region of interest (ROI), as well as adverse events, and it requires minimal commands so that it can be directly controlled by the physician. The second solution visualizes the global picture of all the bifurcations and their relative orientations in advance and suggests the maneuvers needed by the bronchoscope to approach the ROI. Guided bronchoscopy results using human airway-tree phantoms demonstrate the potential of the two solutions. | 2012-08-09 |
20120203066 | ENDOSCOPE, GUIDE UNIT, GUIDE WIRE, MEDICAL-DEVICE GUIDING SYSTEM, AND MEDICAL-DEVICE GUIDING METHOD - An endoscope and a surgical instrument are easily manipulated to desired positions and orientations independently while the state of treatment with the surgical instrument can be easily observed using an endoscopic image. Provided is a medical-device guiding method comprising a U-shape forming step of placing both ends of a guide wire outside the pericardium and placing the guide wire, with an intermediate portion curved in a substantially U-shape in the pericardial cavity; an endoscope inserting step of inserting an endoscope into the pericardial cavity along the guide wire from one end of the ends placed outside the pericardium in the U-shape forming step; a guide-unit inserting step of inserting the guide unit into the pericardial cavity along the guide wire from the other of the ends placed outside the pericardium in the U-shape forming step; and an opposing step of opposing the distal end portions of the endoscope and the guide unit, which are inserted into the pericardial cavity in the endoscope inserting step and the guide-unit inserting step, respectively, at intermediate positions of the guide wire. | 2012-08-09 |
20120203067 | METHOD AND DEVICE FOR DETERMINING THE LOCATION OF AN ENDOSCOPE - A technician-free strategy enables real-time guidance of bronchoscopy. The approach uses measurements of the bronchoscope's movement to predict its position in 3D virtual space. To achieve this, a bronchoscope model, defining the device's shape in the airway tree to a given point p, provides an insertion depth to p. In real time, the invention compares an observed bronchoscope insertion depth and roll angle, measured by an optical sensor, to precalculated insertion depths along a predefined route in the virtual airway tree to predict a bronchoscope's location and orientation. | 2012-08-09 |
20120203068 | CAPSULE GUIDING SYSTEM - A capsule guiding system includes a magnetic guiding unit, a displaying unit, an operation unit, and a control unit. The magnetic guiding unit guides, using magnetic force, a capsule-shaped medical apparatus introduced inside a subject. The displaying unit displays an image of the subject and an image of the capsule-shaped medical apparatus as an overlapped image, and changes relative position and relative direction between the two images as the capsule-shaped medical apparatus is guided by the magnetic guiding unit. The operation unit inputs coordinate information which specifies movement direction of the capsule-shaped medical apparatus. The control unit adjusts coordinate system of the displaying unit and coordinate system of the operation unit to be consistent with each other, transforms the coordinate information input from the operation unit into the coordinate system of the magnetic guiding unit, and controls the guiding of the capsule-shaped medical apparatus based on the transformed coordinate information. | 2012-08-09 |
20120203069 | SURGICAL SHIELD FOR SOFT TISSUE PROTECTION - A soft tissue protection surgical shield protects collateral soft tissue from damage during a surgical procedure within a surgical space of a body. The shield comprises an elongated flexible shield having a proximal end and a distal end. The proximal end has a first opening and the distal end has a second opening. The shield further comprises a side wall between the proximal and distal ends that defines the first and second openings. The side wall is conformal to the surgical space and arranged to resist perforation by surgical instruments in use during the surgical procedure, and also to define and maintain the access pathway to the surgical site. | 2012-08-09 |
20120203070 | METHODS AND DEVICES TO DECREASE TISSUE TRAUMA DURING SURGERY - Methods and devices are disclosed to reduce tissue trauma when a physician retracts a patient's tissues for surgery. In one part, methods and devices are disclosed for controlling retraction force and pace. In another part, methods and devices are disclosed for oscillating force when opening. In another part, methods and devices are disclosed for detecting trauma during retraction. In another part, methods and devices are disclosed for balancing forces on multiple retraction elements. In another part, methods and devices are disclosed for reducing forces in multiple dimensions. In another part, methods and devices are disclosed for engaging ribs. In another part, methods and devices are disclosed to compensate for deformation of a retractor under load. In another part, methods and devices are disclosed that combine these methods and devices. In another part, methods and devices are disclosed for controlling pressure inside inflatable devices used for deforming biological tissues. | 2012-08-09 |
20120203071 | Endoscopic Soft Tissue Working Space Creation - A device for creating endoscopic operating space includes an external cannula, an internal cannula disposed in the external cannula, and an expandable retractor disposed at a distal end of the device and cooperable with the external cannula and the internal cannula. The expandable retractor is displaceable between an unexpanded position and an expanded position. An actuator is cooperable with the expandable retractor to displace the expandable retractor between the unexpanded position and the expanded position. | 2012-08-09 |
20120203072 | Apical Instrument Port - The invention is directed to a method of treating a patient's heart. In this method an instrument port is secured within a passageway through a wall of an apical region of the patient's heart to allow the passage of a treatment instrument. A number of minimally invasive procedures may be performed within the patient's heart | 2012-08-09 |
20120203073 | Endoluminal Access Device - A surgical access apparatus for providing access inside a body includes a housing having a first port, a tubular member extending distally from the housing and defining a longitudinal axis therealong, wherein the tubular member includes a lumen extending therethrough. a shaft insert disposed in the lumen of the tubular member, wherein the shaft insert forms first, second, and third passageways extending along the lumen of the tubular member, wherein each of the first, second, and third passageways is adapted to receive a surgical instrument; and a first seal assembly covering the first port of the housing and defining a first passage disposed in communication with the first passageway defined by the shaft insert in the tubular member, wherein the first seal assembly is adapted to form a seal around the surgical instrument inserted through the first passage of the first seal assembly. | 2012-08-09 |
20120203074 | SURGICAL PORTAL APPARATUS WITH ARMATURE ASSEMBLY - A surgical portal apparatus includes a portal housing, an elongated portal member connected to the portal housing and an armature assembly. The portal housing and the portal member have an axial bore for reception and passage of a surgical object. The armature assembly includes at least two arms disposed within the portal housing and an outer mount. The at least two arms extend at least radially inwardly and are adapted to move relative to the longitudinal axis from a rest position to an activated position during passage of the surgical object. The at least two arms are operatively connected whereby movement of a first arm causes corresponding movement of a second arm. The outer mount comprises a resilient material and is mounted to the at least two arms, and imparts a biasing force thereto toward the rest position. | 2012-08-09 |
20120203075 | White coherent laser light launched into nano fibers for surgical illumination - Disclosed is an exemplary surgical illumination system that includes a first laser configured to emit a first light beam having a first spectral range, and an illumination probe optically connectable to the first laser. The first laser may be configured as a supercontinuum laser. The surgical illumination system may include a second laser configured to emit a second light beam having a second spectral range, and a beam combiner for combing the first and second laser beams to form a third laser beam having a spectral range of the first and second lasers. The illumination probe includes a fiber optic cable for delivering at least a portion of the first light beam to a surgical site. The fiber optic cable includes a fiber optic core having a diameter of 100 microns or less. | 2012-08-09 |
20120203076 | Portable Physiological Data Monitoring Device - A portable monitoring device and a method for monitoring and alerting physiological parameters of a patient are provided. The portable monitoring device comprises a housing, parameter sensing devices, a processing unit, and data communication units. The housing defines an inner surface for establishing physical contact with the patient's body part, and an outer surface opposing the inner surface. The parameter sensing devices acquire physiological data associated with the patient's physiological parameters. The processing unit processes the acquired physiological data and patient information. The data communication units, capable of synchronizing with responder devices, transmit the processed physiological data and the patient information to a base monitoring unit, a remote monitoring station, and/or responder devices via one or more transceivers and data communication interfaces for initiating relief measures. The portable monitoring device monitors the patient's physiological parameters and alerts the remote monitoring station for providing the relief measures to the patient. | 2012-08-09 |
20120203077 | Wearable Vital Signs Monitor - A method and monitor for monitoring vital signs. In one embodiment, the vital signs monitor includes a housing sized and shaped for fitting adjacent the ear of a wearer and an electronic module for measuring vital signs. The electronic module for measuring vital signs is located within the housing and includes a plurality of vital signs sensing modules in communication with a processor. The plurality of sensing modules includes at least two of the modules selected from the group of a ballistocardiographic (BCG) module, a photoplethysmographic (PPG) module, an accelerometer module, a temperature measurement module, and an electrocardiographic (ECG) module. In one embodiment, the processor calculates additional vital signs in response to signals from the plurality of vital signs sensing modules. | 2012-08-09 |
20120203078 | Wireless Patient Monitoring System - A patient monitoring system for monitoring vital signs, comprises: one or more sensors, wherein the sensors measure vital signs; a monitor station; and one or more portable monitoring devices, wherein monitored data based on the measured vital signs is wirelessly transmitted from the sensors to the monitor station, wherein the monitor station issues one or more alarms to certain ones of the portable monitoring devices as a function of the monitored data, and wherein a portion of the monitored data that pertains to the alarms is wirelessly transmitted to the certain ones of the portable monitoring devices and displayed by the certain ones of the portable monitoring devices. | 2012-08-09 |
20120203079 | Wireless, Implantable Electro-Encephalography System - An electro-encephalography system includes an internal device for implantation below a scalp and above a skull of a patient, and an external device to be worn or carried outside the patient's body. The internal device includes a first electrode for receiving neurological signals originating from the patient's brain and a second electrode for receiving artifacts originating from sources other than the patient's brain. The external device includes a processing unit for receiving data from the internal device, mitigating the effects of the artifacts, and determining a neurological state of the patient. A therapy device is included to provide a therapy to the patient based on the patient's neurological state. | 2012-08-09 |
20120203080 | PHOTOPLETHYSMOGRAPHY APPARATUS - A photoplethysmography apparatus is provided. The photoplethysmography includes a plurality of light-emitting units spaced apart from each other and configured to emit light to a measurement part, a light-receiving unit disposed in the center of the light-emitting units and configured to detect transmitted or reflected light from the measurement part by the light-emitting units, a signal pre-processing unit configured to amplify and filter a measurement signal of the light-receiving unit, and a signal processing unit configured to extract a heart rate of a target person using an output signal of the pre-processing unit. The light-emitting units and the light-receiving unit provide a plurality of optical paths, and the light-receiving unit detects spatially averaged reflected or transmitted light at the measurement part. | 2012-08-09 |
20120203081 | PHYSIOLOGICAL AND ENVIRONMENTAL MONITORING APPARATUS AND SYSTEMS - Systems and methods for monitoring various physiological and environmental factors, as well as systems and methods for using this information for a plurality of useful purposes, are provided. Real-time, noninvasive health and environmental monitors include a plurality of compact sensors integrated within small, low-profile devices. Physiological and environmental data is collected and wirelessly transmitted into a wireless network, where the data is stored and/or processed. This information is then used to support a variety of useful methods, such as clinical trials, marketing studies, biofeedback, entertainment, and others. | 2012-08-09 |
20120203082 | TRANSDERMAL ANTENNA - A transdermal antenna may be partially inserted into a cavity in the body of a mammal to receive wireless data transmissions from devices located within the body and relay the data to devices located outside of the body. The transdermal antenna may include a first antenna which may be inserted inside of the body cavity and receive radio frequency data transmissions from devices located inside the body. The transdermal antenna may conduct the received data transmissions to a relay mechanism located outside of the body using coaxial cables, waveguides or a combination of both. The relay mechanism may relay the conducted data transmissions to a receiver device located outside of the body by using a wire connection, such as a coaxial cable, or a wireless communication link via a transceiver coupled to a second antenna. | 2012-08-09 |
20120203083 | Biologocal Test Kit - The biological test kit is a device for drawing and, optionally, testing biological samples. The biological test kit is an array of Lancets set in wells in a rigid base. Each lancet well is covered by a protective cover which when deformed permits the lancet to puncture a user or other patient. In one embodiment the biological test kit employs distinct covers for each lancet and in another the covers are formed from sheet material formed into blisters which cover the lancet. | 2012-08-09 |
20120203084 | POSITIONING SYSTEM, APPARATUS, AND METHOD FOR WIRELESS MONITORING OF ESOPHAGEAL pH VALUE - A positioning system, an apparatus, and a method for wireless monitoring of esophageal pH value. The positioning system includes an internal transmitting apparatus and an external recording apparatus. The external recording apparatus includes a second element, and the second element of the external recording apparatus cooperates with a first element of the internal transmitting apparatus. If the external recording apparatus detects that the internal transmitting apparatus is not located in the preset region, alerting action is conducted under the control of a micro-processor. The external recording apparatus periodically detects the intensity of a signal received by a second wireless transceiver module, under the control of the micro-processor, and if the signal intensity is not within the preset range, the alerting action is conducted under the control of the micro-processor. | 2012-08-09 |
20120203085 | NON-INVASIVE SYSTEM AND METHOD FOR MEASURING AN ANALYTE IN THE BODY - A system for determining an analyte concentration in a fluid sample (e.g., glucose) comprises a light source, a detector, and a central processing unit. The detector is adapted to receive spectral information corresponding to light returned from the fluid sample being analyzed and to convert the received spectral information into an electrical signal indicative of the received spectral information. The central processing unit is adapted to compare the electrical signal to an algorithm built upon correlation with the analyte in body fluid. The algorithm is adapted to convert the received spectral information into the analyte concentration in body fluid. Spectral information is delivered from the central processing unit to the light source and used to vary the intensity and timing of the light to improve the accuracy of conversion into analyte concentration. | 2012-08-09 |
20120203086 | APPARATUS AND METHOD FOR NON-INVASIVELY DETECTING DISEASES THAT AFFECT STRUCTURAL PROPERTIES IN BIOLOGICAL TISSUES - Apparatus and methods for spectroscopic analysis of biological tissues to classify an individual as diabetic or non-diabetic, or to determine the probability, progression or level of a disease or medical condition in an individual. | 2012-08-09 |
20120203087 | SYSTEMS AND METHODS FOR MONITORING DEPTH OF CONSCIOUSNESS - During patient monitoring, a depth of consciousness (DOC) measure, such as a bispectral index, may be used in conjunction with additional information obtained from an awareness metric derived from one or more physiological signals, such as a photoplethysmograph signal. In an embodiment, a DOC measure may be combined with information from an awareness metric to produce a combined DOC measure. In an embodiment, information from an awareness metric derived from one or more physiological signals may be used to provide an indication of confidence in a DOC measure. In an embodiment, a DOC measure may be used to provide an indication of confidence in a depth of consciousness assessment based on an awareness metric. In an embodiment, one or the other of a DOC measure and an awareness metric may be used to provide an indication of a patient's depth of consciousness (e.g., by one “overriding” the other). | 2012-08-09 |
20120203088 | BIOLOGICAL OPTICAL MEASUREMENT INSTRUMENT AND REFERENCE IMAGE DISPLAY METHOD - The biological optical measurement instrument is provided with a mobile position sensor that can move in a 3-dimensional space and that detects spatial position in the 3-dimensional space, a head-surface image creating unit that creates a head-surface image of an object and a head-surface point creating unit that creates, on the head-surface image, a head-surface point corresponding to the spatial position of the mobile position sensor. | 2012-08-09 |
20120203089 | MONITORING SYSTEMS AND METHODS WITH FAST INITIALIZATION - Some embodiments provide a system for synchronizing and configuring monitoring devices. In some embodiments, a patient monitoring device settings module is configured to automatically provide configuration settings to a plurality of patient monitoring devices. A monitoring device data module is configured to receive measurement data from at least one of the patient monitoring devices. An electronic medical records system interface is configured to provide patient data at least partially derived from the received measurement data to an electronic medical records system. A patient records interface is configured to provide patient data to at least one of the patient monitoring devices. | 2012-08-09 |
20120203090 | SYSTEMS AND METHODS FOR TRACKING STROKE VOLUME USING HYBRID IMPEDANCE CONFIGURATIONS EMPLOYING A MULTI-POLE IMPLANTABLE CARDIAC LEAD - Techniques are provided for use with an implantable medical device for assessing stroke volume or related cardiac function parameters such as cardiac output based on impedance signals obtained using hybrid impedance configurations that exploit a multi-pole cardiac pacing/sensing lead implanted near the left ventricle. In one example, current is injected between a large and stable reference electrode and a ring electrode in the RV. The reference electrode may be, e.g., a coil electrode implanted within the superior vena cava (SVC). Impedance values are measured along a set of different sensing vectors between the reference electrode and each of the electrodes of the multi-pole LV lead. Stroke volume is then estimated and tracked within the patient using the impedance values. In this manner, a hybrid impedance detection configuration is exploited whereby one vector is used to inject current and other vectors are used to measure impedance. | 2012-08-09 |
20120203091 | DEVICES AND METHODS FOR MONITORING CEREBRAL HEMODYNAMIC CONDITIONS - Devices, and methods for measuring bioimpedance signals are disclosed. One aspect may include a headset apparatus including a retainer and electrodes. The retainer may be configured to position the electrodes on the head of a subject so as to obtain bioimpedance signals indicative of hemodynamic conditions associated with an MCA territory. A processor may be included to measure and analyze the obtained bioimpedance signals, and to output information for predicting hemodynamic conditions associated with an MCA territory. | 2012-08-09 |
20120203092 | PATIENT HEALTH IMPROVEMENT MONITOR - Systems and methods to monitor an improvement of a subject's physiological condition using a goal improvement profile are described. In an example, a physiological condition of a subject can be compared to a goal improvement profile, where the profile includes at least one target condition indicative of an improved physiological condition detectable using a physiological sensor signal, and a target time when the subject is expected to reach the target condition, where the comparison can be used to indicate whether the subject has met the target condition by the target time. | 2012-08-09 |
20120203093 | APPARATUS, SYSTEM AND METHODS FOR PHOTOACOUSTIC DETECTION OF DEEP VEIN THROMBOSIS - Embodiments of the invention provide apparatus, systems and methods for the detection of deep vein thrombosis (DVT) using photoacoustic measurement of hemoglobin in different states of oxgyenation within tissue. One embodiment of a system for DVT detection comprises at least a first and second light source that emit light at first and second wavelengths, an acoustic transducer, a data converter and a processor. The first and second light sources are directed on the patient's skin to produce a photoacoustic signal (PS) correlated to an amount of absorbance of the first and second wavelengths by a target region of tissue beneath the patient's skin. The acoustic transducer detects the PS and transduces it into an electrical signal which is correlated to the PS. The data converter converts the electrical signal into a digital signal which is analyzed by the processor to detect the presence of DVT within the target region. | 2012-08-09 |
20120203094 | Mobile Architecture Using Cloud for Data Mining Application - Three tier architecture for image-based diagnosis and monitoring application using Cloud is described. The presentation layer is run on the tablet (mobile device), while the business and persistence layer runs on a single cloud or distributed on different Clouds in a multi-tenancy and multi-user application. Such architecture is used for automated data mining application for computing (a) cardiovascular risk, stroke risk using IMT measurement, plaque characterization, (b) computing diagnostic index for benign vs. malignant tissue for ovarian cancer classification (c) benign vs. malignant tissue characterization for prostate cancer and (d) classification of fatty liver disease vs. normal cases. The Architecture is for data mining application. | 2012-08-09 |
20120203095 | Systems and Methods for Trans-Orifice and Transperineal Intervention - An intervention apparatus is described having a probe with an orifice insertion portion, the insertion portion being configured for insertion into an orifice of a patient. The apparatus also having an intervention tool securement and adjustment mechanism removably attached to the probe. The probe providing support to hold the mechanism in a position relative to the patient, and the adjustment mechanism providing adjustment of an entry point and an angle of entry for an intervention tool to the patient. In embodiments, magnetic resonance imaging, trans-orifice intervention and transperineal intervention are described. Methods for imaging and/or intervention are also described. | 2012-08-09 |
20120203096 | METHODS TO DIAGNOSE DEGENERATIVE DISC DISEASE USING PAIN STIMULI - Methods are provided that better describe, and localize the pain generator or suspected pain generator in and around spinal discs in relation to neck, back or leg pain so as to improve the diagnosis of degenerative disc disease. In some embodiments, there are methods for diagnosing a pain generator or a suspected pain generator in a patient suffering from back pain, the methods comprise causing painful stimuli at or near the pain generator or suspected pain generator in the patient suffering from back pain; labeling an inflammatory, vascular, neuronal, and/or metabolic pain marker at a location inside of or adjacent to an intervertebral disc in the patient suffering from back pain to increase an image of the pain marker with an imaging procedure; and imaging the labeled inflammatory, vascular, neuronal, and/or metabolic pain marker in a manner sufficient to diagnose the pain generator or suspected pain generator. | 2012-08-09 |
20120203097 | MAGNETIC RESONANCE IMAGING SYSTEM AND METHOD FOR DETECTING A GAS BUBBLE - A magnetic resonance imaging system ( | 2012-08-09 |
20120203098 | ULTRASOUND POWER SUPPLY FOR AN ULTRASOUND TRANSDUCER - An ultrasound power supply ( | 2012-08-09 |
20120203099 | METHOD AND APPARATUS FOR LOCALIZATION OF INTRODUCED OBJECTS IN INTERVENTIONAL MAGNETIC RESONANCE - In a method and a magnetic resonance system to show an object that is introduced into an examination region, the object having a known chemical shift relative to tissue that is predominant in the examination region, magnetic resonance signals are acquired from the examination region of the subject with the introduced object therein, and the different chemical shift of the introduced object and of the predominant tissue is computationally used in a processor to calculate, from the acquired magnetic resonance signals, a localization image in which substantially only the introduced object is shown. | 2012-08-09 |
20120203100 | RADIO FREQUENCY ABLATION CATHETER AND MAGNETIC RESONANCE IMAGING SYSTEM - A catheter comprising:-a transmission line ( | 2012-08-09 |
20120203101 | METHODS FOR OPTOACOUSTIC GUIDANCE AND CONFIRMATION OF PLACEMENT OF NOVEL INDWELLING MEDICAL APPARATUS - Indwelling medical apparatus including one optoacoustic discernible member or a plurality of optoacoustic discernible members and methods for optoacoustic guidance and confirmation of placement of optoacoustically discernible indwelling medical apparatus. | 2012-08-09 |